The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs ca
The Antibodies & Antibody Drug Conjugates conference will be hosting 2 half day post-conference workshops on the 11th April, presented by BioPharmaLogic, Antikor Biopharma Ltd and UCL.
SMi are delighted to welcome Robert Lyon, Senior Director Protein Sciences, Seattle Genetics Ltd, onto the speaker panel for day 2 at ADC 2018!
About Robert:
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho